184 related articles for article (PubMed ID: 2553308)
1. Variation in lymphoproliferative responses during recrudescent orofacial herpes simplex virus infections.
Vestey JP; Norval M; Howie S; Maingay J; Neill WA
Clin Exp Immunol; 1989 Sep; 77(3):384-90. PubMed ID: 2553308
[TBL] [Abstract][Full Text] [Related]
2. Lymphoproliferative responses in recrudescent orofacial herpetic infections.
Vestey JP; Norval M; Howie SE
J R Soc Med; 1990 May; 83(5):308-11. PubMed ID: 2166159
[TBL] [Abstract][Full Text] [Related]
3. Antigen presentation in patients with recrudescent orofacial herpes simplex virus infections.
Vestey JP; Norval M; Howie SE; Maingay JP; Neill W
Br J Dermatol; 1990 Jan; 122(1):33-42. PubMed ID: 2153401
[TBL] [Abstract][Full Text] [Related]
4. Immunity to herpes simplex virus type 2. IV. Impaired lymphokine production during recrudescence correlates with an imbalance in T lymphocyte subsets.
Sheridan JF; Donnenberg AD; Aurelian L; Elpern DJ
J Immunol; 1982 Jul; 129(1):326-31. PubMed ID: 7045224
[TBL] [Abstract][Full Text] [Related]
5. Immune responses to herpes simplex virus in patients with facial herpes simplex and those with eczema herpeticum.
Vestey JP; Howie SE; Norval M; Maingay JP; Neill WA
Br J Dermatol; 1988 Jun; 118(6):775-82. PubMed ID: 2840941
[TBL] [Abstract][Full Text] [Related]
6. Immunity to herpes simplex virus type 2. V. Risk of recurrent disease following primary infection: modulation of T-cell subsets and lymphokine (LIF) production.
Sheridan JF; Aurelian L
Diagn Immunol; 1983; 1(3):245-56. PubMed ID: 6209056
[TBL] [Abstract][Full Text] [Related]
7. Immunological studies of herpes simplex virus infection in children with atopic eczema.
Goodyear HM; McLeish P; Randall S; Buchan A; Skinner GR; Winther M; Rolland J; Morgan G; Harper JI
Br J Dermatol; 1996 Jan; 134(1):85-93. PubMed ID: 8745891
[TBL] [Abstract][Full Text] [Related]
8. Coinfection with herpes simplex virus type 2 is associated with reduced HIV-specific T cell responses and systemic immune activation.
Sheth PM; Sunderji S; Shin LY; Rebbapragada A; Huibner S; Kimani J; Macdonald KS; Ngugi E; Bwayo JJ; Moses S; Kovacs C; Loutfy M; Kaul R
J Infect Dis; 2008 May; 197(10):1394-401. PubMed ID: 18444797
[TBL] [Abstract][Full Text] [Related]
9. Immunity to herpes simplex virus in children receiving treatment for acute lymphoblastic leukaemia (ALL).
Tellez PA; Odom L; Hayward AR
Clin Exp Immunol; 1985 Dec; 62(3):525-9. PubMed ID: 3002690
[TBL] [Abstract][Full Text] [Related]
10. Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma).
Smith PM; Wolcott RM; Chervenak R; Jennings SR
Virology; 1994 Jul; 202(1):76-88. PubMed ID: 7912023
[TBL] [Abstract][Full Text] [Related]
11. Herpes simplex virus-specific immune responses in subjects with frequent and infrequent orofacial recrudescences.
McKenna DB; Neill WA; Norval M
Br J Dermatol; 2001 Mar; 144(3):459-64. PubMed ID: 11259999
[TBL] [Abstract][Full Text] [Related]
12. Some immunological characteristics of subjects suffering from frequent herpes simplex virus recrudescences.
Doutlík S; Kutinová L; Benda R; Kamínková J; Krcmár M; Votruba T; Suchánková A; Vonka V; Vacek Z
Acta Virol; 1989 Sep; 33(5):435-46. PubMed ID: 2576584
[TBL] [Abstract][Full Text] [Related]
13. Serological responses to herpes simplex virus type 1 (HSV-1) analysed with enzyme-linked immunosorbent assay (ELISA) and western blot (WB).
Rabie-Finger H; Valentine-Thon E; Steinmann J; Nehrkorn A
Acta Virol; 1991 Apr; 35(2):113-26. PubMed ID: 1681709
[TBL] [Abstract][Full Text] [Related]
14. Reconstitution of herpes simplex virus-specific T cell immunity in HIV-infected patients receiving highly active antiretroviral therapy.
Ramaswamy M; Waters A; Smith C; Hainsworth E; Hardy G; Johnson M; Ainsworth J; Phillips A; Geretti AM
J Infect Dis; 2007 Feb; 195(3):410-5. PubMed ID: 17205480
[TBL] [Abstract][Full Text] [Related]
15. Lymphoproliferative and serological responses to herpes simplex virus during primary infection, recrudescence, and re-infection in a murine model.
Maingay JP; Howie SE; Norval M; Moodycliffe AM; Neill WA
Viral Immunol; 1989; 2(2):115-26. PubMed ID: 2789063
[TBL] [Abstract][Full Text] [Related]
16. Specific immunity after congenital or neonatal infection with cytomegalovirus or herpes simplex virus.
Hayward AR; Herberger MJ; Groothuis J; Levin MR
J Immunol; 1984 Nov; 133(5):2469-73. PubMed ID: 6207230
[TBL] [Abstract][Full Text] [Related]
17. Limiting dilution analysis of specific in vitro anti-herpes simplex virus antibody production by human lymphocytes.
Yasukawa M; Kobayashi Y
Clin Exp Immunol; 1987 Apr; 68(1):39-47. PubMed ID: 2820632
[TBL] [Abstract][Full Text] [Related]
18. Cellular interactions in the cytotoxic T lymphocyte response to herpes simplex virus antigens: differential antigen activation requirements for the helper T lymphocyte and cytotoxic T lymphocyte precursors.
Schmid DS; Rouse BT
J Immunol; 1983 Jul; 131(1):479-84. PubMed ID: 6223080
[TBL] [Abstract][Full Text] [Related]
19. Herpes simplex virus-specific human cytotoxic T-cell colonies expressing either gamma delta or alpha beta T-cell receptor: role of accessory molecules on HLA-unrestricted killing of virus-infected targets.
Maccario R; Comoli P; Percivalle E; Montagna D; Locatelli F; Gerna G
Immunology; 1995 May; 85(1):49-56. PubMed ID: 7635521
[TBL] [Abstract][Full Text] [Related]
20. Delayed hypersensitivity and immune protection against herpes simplex virus: suppressor T cells that regulate the induction of delayed hypersensitivity effector T cells also regulate the induction of protective T cells.
Schrier RD; Ishioka GY; Pizer LI; Moorhead JW
J Immunol; 1985 May; 134(5):2889-93. PubMed ID: 2580006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
